Remdesivir in the Treatment of COVID-19: A Propensity Score-Matched Analysis from a Public Hospital in New York City Assessing Renal and Hepatic Safety

Remdesivir in the Treatment of COVID-19: A Propensity Score-Matched Analysis from a Public Hospital in New York City Assessing Renal and Hepatic Safety

While the relative efficacy of remdesivir as a therapeutic agent in selected patients with COVID-19 has been established, safety concerns have been raised regarding potential nephrotoxicity and hepatotoxicity. Our main objective was to investigate the kidney- and liver-related safety outcomes in pat...

Full description

Bibliographic Details
Main Authors: Hyomin Lim, Leonidas Palaiodimos, Cesar G. Berto, Oluwatitomi Tedunjaiye, Paras Malik, Sanjana Nagraj, Hansol Choi, Nang San Hti Lar Seng, Michail Kladas, Amrin Kharawala, Dimitrios Karamanis, Nidhi Varma, Acharya Anjali
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Journal of Clinical Medicine
Subjects:
remdesivir
COVID-19
safety
adverse events
acute kidney injury
nephrotoxicity
Online Access:https://www.mdpi.com/2077-0383/11/11/3132

Internet

https://www.mdpi.com/2077-0383/11/11/3132

Similar Items